MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for the fourth quarter and fiscal year 2015 ended April 30, 2015, and provided a corporate update.
Help employers find you! Check out all the jobs and post your resume.
